• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫反应在预测病毒载量抑制方面的表现:对资源有限环境下患者监测的意义。

Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.

作者信息

Moore David M, Mermin Jonathan, Awor Anna, Yip Benita, Hogg Robert S, Montaner Julio S G

机构信息

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

出版信息

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9. doi: 10.1097/01.qai.0000243105.80393.42.

DOI:10.1097/01.qai.0000243105.80393.42
PMID:17019367
Abstract

BACKGROUND

World Health Organization (WHO) guidelines for the use of antiretroviral therapy (ART) in resource-limited settings state that CD4 cell counts may be used to indicate when ART regimens should be changed because of treatment failure. The performance of immunologic monitoring for this purpose has not been evaluated, however.

METHODS

Participants aged > or =18 years from the British Columbia HIV/AIDS Drug Treatment Program who had CD4 cell counts < or =200 cells/microL or an AIDS diagnosis at baseline had CD4 cell counts measured at 6 and 12 months after treatment initiation. Logistic regression analysis was used to calculate sensitivity, specificity, and positive and negative predictive values for immunologic responses in terms of predicting failure to achieve 2 viral load measurements < 500 copies/mL within 1 year.

RESULTS

Viral load suppression occurred in 674 (60%) of 1125 subjects. Using no increase in CD4 cell counts at 6 months as a definition of treatment failure had a sensitivity of 34%, specificity of 94%, positive predictive value of 75%, and negative predictive value of 71% for predicting failure to achieve virologic suppression. Using 12-month CD4 cell count values, the measurements were 35%, 95%, 79%, and 73%, respectively.

CONCLUSION

Immunologic criteria to predict which patients have not achieved virologic suppression results in significant misclassification of therapeutic responses.

摘要

背景

世界卫生组织(WHO)关于在资源有限环境中使用抗逆转录病毒疗法(ART)的指南指出,CD4细胞计数可用于指示何时应因治疗失败而更改ART方案。然而,尚未评估用于此目的的免疫监测的性能。

方法

来自不列颠哥伦比亚省HIV/艾滋病药物治疗项目的年龄≥18岁、基线时CD4细胞计数≤200个/微升或被诊断为艾滋病的参与者在开始治疗后6个月和12个月测量CD4细胞计数。逻辑回归分析用于计算免疫反应在预测1年内未能实现2次病毒载量测量<500拷贝/毫升方面的敏感性、特异性、阳性预测值和阴性预测值。

结果

1125名受试者中有674名(60%)实现了病毒载量抑制。将6个月时CD4细胞计数未增加作为治疗失败的定义,在预测未能实现病毒学抑制方面的敏感性为34%,特异性为94%,阳性预测值为75%,阴性预测值为71%。使用12个月时的CD4细胞计数,相应的测量值分别为35%、95%、79%和73%。

结论

用于预测哪些患者未实现病毒学抑制的免疫标准会导致治疗反应的显著错误分类。

相似文献

1
Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.免疫反应在预测病毒载量抑制方面的表现:对资源有限环境下患者监测的意义。
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9. doi: 10.1097/01.qai.0000243105.80393.42.
2
"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.在一组密切随访的开始抗逆转录病毒治疗的患者中,CD4细胞计数相对于血浆病毒载量出现“不一致”的增加。
J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66. doi: 10.1097/00042560-200206010-00004.
3
Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.在资源有限的环境中,CD4细胞计数对抗逆转录病毒治疗期间病毒学失败的早期预测价值。
BMC Infect Dis. 2008 Jul 4;8:89. doi: 10.1186/1471-2334-8-89.
4
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.评估印度二线抗逆转录病毒治疗患者:靶向病毒载量检测的作用。
J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):610-4. doi: 10.1097/QAI.0b013e3181f43a31.
5
Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.免疫标准是对病毒学结果的不良预测指标:对资源有限环境下的 HIV 治疗监测的影响。
Clin Infect Dis. 2011 Dec;53(12):1283-90. doi: 10.1093/cid/cir729.
6
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.在资源匮乏地区,针对感染艾滋病毒的成人和青少年治疗失败时何时更换一线抗逆转录病毒治疗方案的最佳监测策略。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD008494. doi: 10.1002/14651858.CD008494.
7
Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.接受联合抗逆转录病毒治疗的泰国患者免疫和病毒学终点的预测因素。
HIV Med. 2007 Jan;8(1):46-54. doi: 10.1111/j.1468-1293.2007.00427.x.
8
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.接受抗逆转录病毒治疗失败的HIV感染患者治疗中断后恢复治疗持续应答的预测因素。
J Med Virol. 2004 Feb;72(2):181-6. doi: 10.1002/jmv.10580.
9
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.在资源有限的环境中,总淋巴细胞计数作为CD4细胞计数的一种可能替代指标,用于确定HIV感染者中抗逆转录病毒治疗的优先资格。
Antivir Ther. 2003 Oct;8(5):379-84.
10
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.1996 - 1998年阿基坦队列中三联抗逆转录病毒疗法下病毒载量与CD4 +细胞计数联合反应的预后因素
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):161-7. doi: 10.1097/00126334-200106010-00011.

引用本文的文献

1
A Comparison of Adherence and CD4 Cell Count with Respect to Virologic Failure Among HIV-Infected Adults Under Combination Antiretroviral Therapy (cART) at Felege Hiwot Teaching and Specialized Hospital, Bahir Dar, Ethiopia.埃塞俄比亚巴赫达尔市费莱格希沃特教学与专科医院接受联合抗逆转录病毒疗法(cART)的HIV感染成人中,依从性和CD4细胞计数与病毒学失败的比较
HIV AIDS (Auckl). 2022 Feb 2;14:33-44. doi: 10.2147/HIV.S346358. eCollection 2022.
2
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.HIV 相关隐球菌性脑膜炎的全球疾病负担:最新分析
Lancet Infect Dis. 2017 Aug;17(8):873-881. doi: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5.
3
Concurrent use of Antiretroviral and African traditional medicines amongst people living with HIV/AIDS (PLWA) in the eThekwini Metropolitan area of KwaZulu Natal.
夸祖鲁-纳塔尔省伊泰夸尼都会区感染艾滋病毒/艾滋病者同时使用抗逆转录病毒药物和非洲传统药物的情况。
Afr Health Sci. 2016 Dec;16(4):1118-1130. doi: 10.4314/ahs.v16i4.30.
4
Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting.在资源有限的环境中评估提供者记录的临床状态在HIV阳性成年人医疗记录中的效用。
Int J STD AIDS. 2017 Jun;28(7):685-692. doi: 10.1177/0956462416663990. Epub 2016 Aug 5.
5
Initiation of antiretroviral therapy.抗逆转录病毒疗法的启动。
Indian J Sex Transm Dis AIDS. 2014 Jan;35(1):1-11. doi: 10.4103/0253-7184.132399.
6
Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.2007 - 2010年参与津巴布韦国家抗逆转录病毒治疗项目的HIV感染患者的留存率、临床结局及与退出相关的因素
PLoS One. 2014 Jan 29;9(1):e86305. doi: 10.1371/journal.pone.0086305. eCollection 2014.
7
Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India.评价世界卫生组织免疫治疗失败标准:对印度病毒学失败检测、耐药性演变和二线治疗选择的影响。
J Int AIDS Soc. 2013 Jun 3;16(1):18449. doi: 10.7448/IAS.16.1.18449.
8
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review.中低收入国家抗逆转录病毒治疗 12 个月后的病毒抑制:系统评价。
Bull World Health Organ. 2013 May 1;91(5):377-385E. doi: 10.2471/BLT.12.112946. Epub 2013 Feb 21.
9
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.评估肯尼亚布西亚艾滋病毒/艾滋病治疗队列中预测病毒学失败的临床和免疫学标志物。
PLoS One. 2012;7(11):e49834. doi: 10.1371/journal.pone.0049834. Epub 2012 Nov 21.
10
Performance of immunological response in predicting virological failure.免疫反应在预测病毒学失败中的表现。
AIDS Res Hum Retroviruses. 2013 Mar;29(3):541-6. doi: 10.1089/AID.2012.0266. Epub 2012 Dec 16.